Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Intracerebroventricular Dopamine in Parkinson's Disease (Motor Fluctuations)
2024-517566-42-00Phase 2Completed
- Sponsor
- CHU de Lille
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dopamine in Parkinson's disease (PD), sponsored by CHU de Lille. Started Nov 2024; status: completed.
02
Drugs
dopamine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2024-517566-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517566-42-00.